Chemotheraphy-induced Nausea and Vomitting Treatment Market Report

Global and Region Chemotheraphy-induced Nausea and Vomitting Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：150
  • REPORT CODE：GMM910404
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chemotheraphy-induced Nausea and Vomitting Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chemotheraphy-induced Nausea and Vomitting Treatmentmarket, defines the market attractiveness level of Chemotheraphy-induced Nausea and Vomitting Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chemotheraphy-induced Nausea and Vomitting Treatment industry, describes the types of Chemotheraphy-induced Nausea and Vomitting Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chemotheraphy-induced Nausea and Vomitting Treatment market and the development prospects and opportunities of Chemotheraphy-induced Nausea and Vomitting Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chemotheraphy-induced Nausea and Vomitting Treatment market in Chapter 13.

    By Player:

    • FHoffmann La Roche

    • Merck & Co

    • Especificos Stendhal

    • Eisai

    • Mylan Pharmaceuticals

    • Helsinn

    • GlaxoSmithKline

    • Acacia Pharma

    • Aphios

    • OPKO Health

    • Heron Therapeutics

    • Barr Laboratories

    • Orchid Healthcare

    • Tesaro

    • Baxter Healthcare

    • Mundipharma

    By Type:

    • Aloxi (Palonosetron)

    • Kytril (Granisetron)

    • Emend (Aprepitant)

    • Others

    By End-User:

    • Acute Nausea and Vomitting Treatment

    • Delayed Nausea and Vomitting Treatment

    • Anticipatory Nausea and Vomitting Treatment

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chemotheraphy-induced Nausea and Vomitting Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chemotheraphy-induced Nausea and Vomitting Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.2 United States Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.4 China Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.5 Japan Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.6 India Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    • 7.7 South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Consumption (2017-2022)

    8 Region and Country-wise Chemotheraphy-induced Nausea and Vomitting Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.4 China Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.6 India Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast (2022-2028)

    9 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aloxi (Palonosetron) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Kytril (Granisetron) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Emend (Aprepitant) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Acute Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Delayed Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Anticipatory Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    10 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Aloxi (Palonosetron) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Kytril (Granisetron) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Emend (Aprepitant) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Acute Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Delayed Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Anticipatory Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chemotheraphy-induced Nausea and Vomitting Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Competitive Analysis

    • 14.1 FHoffmann La Roche

      • 14.1.1 FHoffmann La Roche Company Details

      • 14.1.2 FHoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 FHoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.2 Merck & Co

      • 14.2.1 Merck & Co Company Details

      • 14.2.2 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.3 Especificos Stendhal

      • 14.3.1 Especificos Stendhal Company Details

      • 14.3.2 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.4 Eisai

      • 14.4.1 Eisai Company Details

      • 14.4.2 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.5 Mylan Pharmaceuticals

      • 14.5.1 Mylan Pharmaceuticals Company Details

      • 14.5.2 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.6 Helsinn

      • 14.6.1 Helsinn Company Details

      • 14.6.2 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.7 GlaxoSmithKline

      • 14.7.1 GlaxoSmithKline Company Details

      • 14.7.2 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.8 Acacia Pharma

      • 14.8.1 Acacia Pharma Company Details

      • 14.8.2 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.9 Aphios

      • 14.9.1 Aphios Company Details

      • 14.9.2 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.10 OPKO Health

      • 14.10.1 OPKO Health Company Details

      • 14.10.2 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.11 Heron Therapeutics

      • 14.11.1 Heron Therapeutics Company Details

      • 14.11.2 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.12 Barr Laboratories

      • 14.12.1 Barr Laboratories Company Details

      • 14.12.2 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.13 Orchid Healthcare

      • 14.13.1 Orchid Healthcare Company Details

      • 14.13.2 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.14 Tesaro

      • 14.14.1 Tesaro Company Details

      • 14.14.2 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.15 Baxter Healthcare

      • 14.15.1 Baxter Healthcare Company Details

      • 14.15.2 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • 14.16 Mundipharma

      • 14.16.1 Mundipharma Company Details

      • 14.16.2 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chemotheraphy-induced Nausea and Vomitting Treatment

    • Figure Chemotheraphy-induced Nausea and Vomitting Treatment Picture

    • Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chemotheraphy-induced Nausea and Vomitting Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption by Country (2017-2022)

    • Figure United States Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aloxi (Palonosetron) Consumption and Growth Rate (2017-2022)

    • Figure Global Kytril (Granisetron) Consumption and Growth Rate (2017-2022)

    • Figure Global Emend (Aprepitant) Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Delayed Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Anticipatory Nausea and Vomitting Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Aloxi (Palonosetron) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kytril (Granisetron) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Emend (Aprepitant) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Delayed Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anticipatory Nausea and Vomitting Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chemotheraphy-induced Nausea and Vomitting Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table FHoffmann La Roche (Foundation Year, Company Profile and etc.)

    • Table FHoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table FHoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Especificos Stendhal (Foundation Year, Company Profile and etc.)

    • Table Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Mylan Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Helsinn (Foundation Year, Company Profile and etc.)

    • Table Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Acacia Pharma (Foundation Year, Company Profile and etc.)

    • Table Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Aphios (Foundation Year, Company Profile and etc.)

    • Table Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table OPKO Health (Foundation Year, Company Profile and etc.)

    • Table OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Heron Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Barr Laboratories (Foundation Year, Company Profile and etc.)

    • Table Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Orchid Healthcare (Foundation Year, Company Profile and etc.)

    • Table Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Tesaro (Foundation Year, Company Profile and etc.)

    • Table Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Baxter Healthcare (Foundation Year, Company Profile and etc.)

    • Table Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service

    • Table Mundipharma (Foundation Year, Company Profile and etc.)

    • Table Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US